Tech Company Financing Transactions

Mevion Medical Systems Funding Round

Mevion Medical Systems closed a $55 million funding round on 6/27/2013. Backers included Caxton Advantage Life Sciences, CHL Medical Partners and Life Sciences Alternative Funding.

Transaction Overview

Announced On
6/27/2013
Transaction Type
Debt
Venture Equity
Amount
$55,000,000
Round
Undisclosed
Proceeds Purpose
The company will use the funding to accelerate the deployment of its cancer treatment technology.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
300 Foster St.
Littleton, MA 01460
USA
Email Address
Not Recorded
Overview
Mevion Medical Systems, Inc. is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical realities.
Profile
Mevion Medical Systems LinkedIn Company Profile
Social Media
Mevion Medical Systems Company Twitter Account
Company News
Mevion Medical Systems News
Facebook
Mevion Medical Systems on Facebook
YouTube
Mevion Medical Systems on YouTube

Management Team

Title
Name
Email & Social
Chairman
Lawrence Tian
  Lawrence Tian LinkedIn Profile  Lawrence Tian Twitter Account  Lawrence Tian News  Lawrence Tian on Facebook
Chief Executive Officer
Tina Yu
  Tina Yu LinkedIn Profile  Tina Yu Twitter Account  Tina Yu News  Tina Yu on Facebook
President
James Meng
  James Meng LinkedIn Profile  James Meng Twitter Account  James Meng News  James Meng on Facebook
Vice President
Stanley Rosenthal
  Stanley Rosenthal LinkedIn Profile  Stanley Rosenthal Twitter Account  Stanley Rosenthal News  Stanley Rosenthal on Facebook
VP - Engineering
Mark Jones
  Mark Jones LinkedIn Profile  Mark Jones Twitter Account  Mark Jones News  Mark Jones on Facebook
VP - Operations
Curt Kienast
  Curt Kienast LinkedIn Profile  Curt Kienast Twitter Account  Curt Kienast News  Curt Kienast on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/27/2013: Blu Homes venture capital transaction
Next: 6/27/2013: Catabasis Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary